Total Hip Arthroplasty Performed in Patients with Residual Poliomyelitis: Does it Work?

Yoon, Byung‐Ho; Lee, Yong Seuk; Yoo, Jeong Joon; Kim, Hee Joong; Koo, Kyung‐Hoi

doi:10.1007/s11999-013-3338-3

Cited by 37 publications

(62 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Four out of five patients were pain free at the end of followup and all considered that they were satisfied with the procedure, despite the complications experienced by some of them. These clinical results are comparable to those of the most recently published series by Yoon et al .,5 except for the fact that in their study only 30% of patients completely considered themselves pain free versus the rate of four out of five in the present study.…”

Section: Discussionsupporting

confidence: 90%

“…Given the small sample size in these series, it is difficult to find statistically significant differences in the correction of limb length discrepancy. In our series, this was considerably reduced in most cases (with a 13 mm median decrease), comparable to the degree of correction found in the series of paretic limbs of the article wrote by Yoon et al 5. of 14 mm.…”

Section: Discussionsupporting

confidence: 89%

“…However, many surgeons are still reluctant to perform this procedure in patients of post polio residual paralysis. The published literature to date describing its clinical results is scanty, limited to several case reports and a series that includes four paretic limb cases 56789…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Total hip arthroplasty in patients of post polio residual paralysis: A retrospective case series

et al. 2017

View full text Add to dashboard Cite

Background:Poliomyelitis is a viral, nervous system disease that affects both the upper and the lower extremities. The treatment of severe coxarthrosis in these patients with total hip arthroplasty (THA) has been widely questioned because of the high risk of subsequent complications. The aim of the present study was to describe both radiological and medium term clinical results in a series of patients with post polio residual paralysis that underwent THA.Materials and Methods:We report a retrospective review of a series of 5 five patients diagnosed with severe coxarthrosis secondary to post polio residual paralysis who were operated between 2008 and 2012. Uncemented THA was performed in all cases by the same surgeon. Clinical evaluation was carried out using the Harris Hip Score (HHS) at the preoperative visit, at 6 months, and annually after surgery.Results:The median age was 47 years, and the median followup was 55 months (interquartile range P25–P75: range 31–72 months). According to the HHS, a significant clinical improvement was observed in all patients with a median score of 81 points (interquartile range P25–P75: range 74–89) at 1 year of followup. A case of relapsing dislocation that required revision surgery of the implant was recorded. No cases of component loosening were found.Conclusion:THA surgery in patients with post polio residual paralysis is a complex procedure with a significant complication rate, but a predictable clinical improvement may encourage surgeons to perform in patients with severe coxarthrosis and moderate functional expectations.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Total hip arthroplasty in patients of post polio residual paralysis: A retrospective case series

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Patients with Parkinson disease who underwent hip replacement overwhelmingly had good-to-excellent pain relief, although approximately one-third experienced a complication and 8% required a repeated operation. 11 In poliomyelitis, which, in contrast to MS, is a lower motor neuron disease, hip and knee replacement 12,13 resulted in universal pain relief and was associated with a very low rate of hip dislocations. In stroke, an upper motor neuron disease that can cause spastic hemiparesis-or paraparesis-like MS, no difference in mortality rates after arthroplasty were observed in patients older than 50 years compared with control patients of the same age.…”

Section: Discussionmentioning

confidence: 99%

Total Hip and Knee Arthroplasty in Patients with Multiple Sclerosis

Gutman¹,

Kim²,

Schwarzkopf³

et al. 2018

International Journal of MS Care

View full text Add to dashboard Cite

CME/CNE Information Activity Available Online: To access the article, post-test, and evaluation online, go to http://www.cmscscholar.org. Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives: Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physician Credit The CMSC designates this journal-based activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse Credit The CMSC designates this enduring material for 0.5 contact hours (none in the area of pharmacology). Disclosures: Editor in Chief of the International Journal of MS Care (IJMSC), has served as Physician Planner for this activity. He has disclosed no relevant financial relationships.Francois Bethoux, MD, has served as reviewer for this activity. She has disclosed no relevant financial relationships.Laurie Scudder, DNP, NP, has disclosed no relevant financial relationships.Josef Maxwell Gutman, MD, has disclosed no relevant financial relationships.Kelvin Kim, BA, has received consulting fees from Smith & Nephew and Intelijoint that are unrelated to this work.Ran Schwarzkopf, MD, MSc, served on the scientific advisory boards for Biogen and Genentech and received research support from the Guthy-Jackson Charitable Foundation, National Multiple Sclerosis Society, Biogen, EMD Serono, Genzyme, and Novartis.Ilya Kister, MD, One peer reviewer for the IJMSC has received consulting fees from Biogen, Sanofi Genzyme, Ibsen Pharmaceutical, and Teva and has done contracted research for Astellas, Merck, and Biogen. The other peer reviewer has disclosed no relevant financial relationships. The staff at the IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships. Note: Disclosures listed for authors are those applicable at the time of their work on this project and within the previous 12 months. Method of Participation: Release Date: October 1, 2018 Valid for Credit Through: October 1, 2019 In order to receive CME/CNE credit, participants must: Statements of Credit are awarded upon successful completion of the post-test with a passing score of >70% and the evaluation. There is no fee to participate in this activity. Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group. Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.

show abstract

“…Yoon et al berichten in der ersten grö-ßeren Studie zur Implantation einer zementfreien Hüftendoprothese über 10 Patienten mit Poliomyelitis, von denen 4 am paralytischen und 6 am nicht paralytischen Bein operiert wurden [22]. Innerhalb des durchschnittlichen Followup von 3 Jahren zeigte sich in dieser Serie keine Lockerung oder periprothetische Osteolyse.…”

Section: Pfannenfixierungunclassified